High-constitutive HuR phosphorylation at Ser 318 by PKCδ propagates tumor relevant functions in colon carcinoma cells

Carcinogenesis

Volumn 32, Issue 5, 2011, Pages 676-685

  Doller, Anke ^a   Winkler, Christine ^a   Azrilian, Irina ^a   Schulz, Sebastian ^a   Hartmann, Sylvia ^a   Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; CYCLIN A; CYCLOOXYGENASE 2; HUR PROTEIN; MESSENGER RNA; PROTEIN KINASE C DELTA; RIBONUCLEOPROTEIN; SERINE; SMALL INTERFERING RNA;

ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 79955780590     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr024     Document Type: Article

References (40)

1. Ma, W.J. et al. (1996) Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem., 271, 8144-8151.
2. Fan, X.C. et al. (1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J., 17, 3448-3460.
3. Abdelmohsen, K. et al. (2007) Posttranscriptional orchestration of an antiapoptotic program by HuR. Cell Cycle, 6, 1288-1292.
4. Eberhardt, W. et al. (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther., 114, 56-73.
5. Doller, A. et al. (2008) Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal., 20, 2165-2173.
6. López de Silanes, I. et al. (2005) HuR: post-transcriptional paths to malignancy. RNA Biol., 2, 11-13.
7. Mazan-Mamczarz, K. et al. (2008) Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene, 27, 6151-6163.
8. Nabors, L.B. et al. (2001) HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res., 61, 2154-2161.
9. Denkert, C. et al. (2004) Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res., 10, 5580-5586.
10. Heinonen, M. et al. (2005) Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res., 65, 2157-2161.
11. Erkinheimo, T.L. et al. (2003) Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res., 63, 7591-7594.
12. Costantino, C.L. et al. (2009) The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res., 69, 4567-4572.
13. Niesporek, S. et al. (2008) Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression. Int. J. Oncol., 32, 341-347.
14. Cho, N.P. et al. (2007) Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas. Pathology, 39, 545-550.
15. Wang, J. et al. (2009) The expression of RNA-binding protein HuR in nonsmall cell lung cancer correlates with vascular endothelial growth factor-C expression and lymphe node metastasis. Oncology, 76, 420-429.
16. Dixon, D.A. et al. (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest., 108, 1657-1665.
17. Denkert, C. et al. (2006) Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod. Pathol., 19, 1261-1269.
18. Lim, S.J. et al. (2009) Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer. Cancer Res. Treat., 41, 87-92.
19. Li, H. et al. (2002) Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J. Biol. Chem., 277, 44623-44630.
20. Kim, H.H. et al. (2008) Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev., 22, 1804-1815.
21. Abdelmohsen, K. et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell., 25, 543-557.
22. Lafarga, V. et al. (2009) p38 Mitogen-activated protein kinase- and HuRdependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell. Biol., 29, 4341-4351.
23. Doller, A. et al. (2007) Protein kinase C α-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol. Biol. Cell., 18, 2137-2148.
24. Doller, A. et al. (2008) Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cδ elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol. Cell. Biol., 28, 2608-2625.
25. Doller, A. et al. (2010) Tandem phosphorylation of serines 221 and 318 by protein kinase Cδ coordinates mRNA binding and nucleocytoplasmic shuttling of HuR. Mol. Cell. Biol., 30, 1397-1310.
26. Kikkawa, U. et al. (2002) Protein kinase C δ (PKC δ): activation mechanisms and functions. J. Biochem., 132, 831-839.
27. Steinberg, S.F. (2004) Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem. J., 384, 449-459.
28. Mackay, H.J. et al. (2007) Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer, 7, 554-562.
29. Pongracz, J. et al. (1995) Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int. J. Cancer, 61, 35-39.
30. Griner, E.M. et al. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer, 7, 281-294.
31. Eberhardt, W. et al. (2002) Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-jB and Ets transcription factors. Mol. Endocrinol., 6, 1752-1766.
32. Albini, A. et al. (1987) Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J. Cell Biol., 105, 1867-1872.
33. Wang, W. et al. (2000) HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J., 19, 2340-2350.
34. Bain, J. et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J., 408, 297-215.
35. Reyland, M.E. (2007) Protein kinase Cdelta and apoptosis. Biochem. Soc. Trans., 35, 1001-1004.
36. DeVries, T.A. et al. (2002) Nuclear import of PKC( is required for apoptosis: identification of a novel nuclear import sequence. EMBO J., 21, 6050-6060.
37. DeVries-Seimon, T.A. et al. (2007) Induction of apoptosis is driven by nuclear retention of protein kinase C δ. J. Biol. Chem., 282, 22307-22314.
38. Wang, Q. et al. (2003) Induction of cIAP-2 in human colon cancer cells through PKC δ/NF-κB. J. Biol. Chem., 278, 51091-51099.
39. Wang, Q. et al. (2006) PKCδ -mediated regulation of FLIP expression in human colon cancer cells. Int. J. Cancer, 118, 326-334.
40. Prescott, S.M. et al. (2000) Cyclooxygenase. -2 and carcinogenesis. Biochim. Biophys. Acta, 1470, M69-M78.